The present invention represents an in vitro implementable method and related kit for assessing the response to immune tolerance restoration therapy by evaluating the expression of specific microRNAs (miRNAs) as biomarkers of residual beta-cell function.

Settore:

Life sciences

Research Institution:

Università degli Studi di Siena

Publication number:

GB201805329A

TRL:

3

Technologies, Systems, Applications:

Medical devices development,
New drugs development

Technological Priority:

Biotechnologies for health,
Biomedical, pharmaceutical, pharmacological technologies
Pubblicato il: